IRCT20200328046886N1 IRCT 2020-04-12 Mazandaran University of Medical Sciences The effectiveness of Sovodak (sofosbuvir+daclatasvir) in Covid-19 patients Evaluation of efficacy and safety of Sovodak (Sofosbuvir+Daclatasvir) in combination with Ribavirin for mild to moderate hospitalized Covid-19 patients compared to standard care regimen (a randomized controlled trial) 2020-03-05 anticipated 48 Complete https://irct.ir/trial/46885 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients will be randomized in a 1:1 ratio into one of the treatment groups and standard of care group using computer generated randomization plan. The date and time of randomization will be recorded. Allocation concealment will be done with the sealed envelope method, Blinding description: clinical pharmacist who assess outcomes and the statistician analyzing the data will not be blinded.Physicians who treat patients and the patients will be blinded. 3 The effectiveness of Sovodak in patients with novel Corona Virus. Intervention 1: Intervention group: sovodak+ribavirin. Intervention 2: Control group: standard care regimen. Yes - There is a plan to make this available What will be shared: all collected deidentified IPD When: starting 1 month after publication To whom: people working in academic institutions Conditions: in situation that invastigator willing Where to obtain: email addresses How to obtain: in short time after request with email will be available Comments: